Stocks and Investing
Stocks and Investing
Mon, August 12, 2024
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
Serge Belanger Maintained (XENE) at Strong Buy with Decreased Target to $60 on, Aug 12th, 2024
Serge Belanger of Needham, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Strong Buy with Decreased Target from $62 to $60 on, Aug 12th, 2024.
Serge has made no other calls on XENE in the last 4 months.
There are 4 other peers that have a rating on XENE. Out of the 4 peers that are also analyzing XENE, 0 agree with Serge's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Serge
- Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $65 on, Friday, August 9th, 2024
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $49 on, Friday, August 9th, 2024
- Brian Abrahams of "RBC Capital" Reiterated at Buy and Held Target at $55 on, Tuesday, June 18th, 2024
- David Hoang of "Citigroup" Maintained at Strong Buy with Decreased Target to $60 on, Friday, May 10th, 2024
Contributing Sources